Lockdown Sceptics Archived Posts

For archived Lockdown Sceptics posts.

Nicola Sturgeon Speeds up Scottish Lockdown Roadmap

There is “every reason for optimism” in Scotland because of its vaccine rollout, according to Nicola Sturgeon, as the next step of the country’s exit from lockdown has been brought forward. The Mail has the story.

The First Minister said from Friday stay local rules are being dropped in Scotland, and six people from six different households will be allowed to meet outdoors – with under-12s not included in the numbers.

Ms Sturgeon also confirmed that that non-essential shops will be allowed to open from April 26th – and boasted there will also be limited hospitality permitted indoors, three weeks earlier than in England.

The move, announced at a briefing in Edinburgh, could increase pressure on Boris Johnson to accelerate the pace south of the border.

However, the PM insisted earlier that although infections and deaths are tumbling people must still be “cautious” about using new-found freedoms.

The Scottish Tories pointed out that Ms Sturgeon’s previous plan was “slow” and welcomed her recognition it was “safe” to go faster. 

Ms Sturgeon said “significant progress” has been made in reducing the number of Covid cases in Scotland.

Figures are now at their lowest since September, and have fallen by 40% in the past two weeks.

“We are now extremely confident that those parts of the country currently in Level 4 will move to Level 3 on April 26th, that’s now less that two weeks away,” she said.

“That means, amongst other things, that on that day shops will fully reopen, pubs, cafes and restaurants will also be able to fully open outdoors on April 26th and will be able to open indoors on that date, but on a restricted basis.”

Despite the success of England’s vaccine rollout, and the fact that Covid cases have all but vanished in many areas across the country, the Government is showing an unwillingness to speed up the exit from lockdown.

The Mail’s report is worth reading in full.

Mick Jagger Comes Out as a Lockdown Sceptic

A number of famous musicians have nailed their colours to the good ship lockdown sceptics in the past 12 months, including Van Morrison and Eric Clapton, but none quite as illustrious as the latest addition to our ranks: Sir Mick Jagger. The Rolling Stones frontman has released a song today called “Eazy Sleazy“, a collaboration with David Grohl of the Foo Fighters. “It’s a song that I wrote about coming out of lockdown, with some much needed optimism,” says Jagger.

If you watch this YouTube version of the song, complete with the lyrics, you’ll find a number of anti-lockdown messages:

We took it on the chin
The numbers were so grim
Bossed around by pricks
Stiffen upper lips
Yeah

Pacing in the yard
You’re trying to take the Mick
You must think I’m really thick
Looking at the graphs
With a magnifying glass
Cancel all the tours
Football’s fake applause
Yeah

No more travel brochures
Virtual premiers
I’ve got nothing left to wear

Looking out from these prison walls
You got to rob Peter if you’re paying Paul
But it’s easy, easy
Everything’s going to get really freaky
Alright, on the night

Soon it’ll be a memory you’re trying to remember to forget…

That’s a pretty mask
But never take a chance
Tik Tok stupid dance
Took a Samba class
Yeah

I landed on my ass
Trying to write a tune
You better hook me up to Zoom
See my poncey books
Teach myself to cook
Way too much TV
It’s lobotomising me
Yeah

Think I’ve put on weight
I’ll have another drink
Then I’ll clean the kitchen sink

We’ll escape from these prison walls
Open the windows and open the doors
But it’s easy, easy
Everything’s going to get really freaky
Alright, on the night
It’s gonna be a garden of earthly delights
Yeah it’s easy, sleazy
Everything’s smooth and greasy
Yeah

Easy, believe me
It’ll only be a memory you’re trying to remember to forget

However, lest you think Jagger has become a full-blown conspiracy theorist, there’s a swipe at some of the crazier fringes of lockdown scepticism in the final verse:

Shooting the vaccine
Bill Gates is in my blood stream
It’s mind control
The earth is flat and cold
It’s never warming up
The Arctic’s turned to slush
The second’s coming late
And there’s aliens in the deep state

Covid Testing Firm Cutting PCR Travel Test Cost to £60

A major UK Covid testing firm is set to halve the cost of its PCR test kit for travel to £60. This means that when overseas travel returns, testing costs will add almost £250 to the bill for a family of four (returning from a “green list” country) as opposed to almost £500 – a more feasible, yet still hefty sum. The Independent has the story.

Randox, based in Northern Ireland, says it will offer the test for just £60 to airline passengers – though the Independent understands negotiations are not yet complete.

At present international leisure travel from the UK is illegal. The Government has indicated it will allow overseas trips from May 17th – but says that all returning travellers must take at least one PCR test after arrival.

These tests, which require specialist equipment to analyse, typically cost £120 – representing almost £500 for a family of four.

The County Antrim firm is the first to announce a significant cut.

The Managing Director of Randox, Dr Peter FitzGerald, said: “In recognition of the needs of both the travel industry and the British public at this unprecedented time, Randox will reduce the all-inclusive cost of PCR testing for those in the UK undertaking international travel to £60 per test.

“We can see the pressures faced by both the travel industry and the general public and are committed to effective and economical testing to support holidaymakers and those undertaking international travel.” 

Even those travelling to “green list” countries on the Government’s “traffic light” system will have to take one test when returning to the UK, as the Telegraph recently reported.

Travellers who want to visit countries on the safe “green list” will still be expected to pay for gold standard PCR tests on their return to the UK…

People who have been fully vaccinated will still be required to take the PCR tests on or before the second day of their arrival back in the UK because of Government concerns that “green list” countries could still harbour new Covid variants.

Holidaymakers arriving from those countries will not have to spend any time in quarantine under the new traffic light system, which is expected to replace the current ban on foreign travel from May 17th.

The Independent’s report is worth reading in full.

Outdoor Sports Events Should Be Open to All, Including the Unvaccinated

Last week, the UK’s sports bodies wrote a joint letter to the leaders of the main political parties. It warned that the return of some spectators from May 17th will be “insufficient to end sport’s Covid financial crisis” because attendance will be capped at 25% of capacity in larger venues.

“Looking ahead to June 21,” the letter went on, “we support the Government’s ambition to secure the full return of fans, without restrictions if possible.” However, it also said, “All of our sports can see the benefit that a Covid certification process offers in getting more fans safely back to their sport as quickly as possible.”

In other words: the sports bodies want to get fans back into bleachers as soon as possible, preferably without restrictions, but if using vaccine passports is what it takes, then so be it.

However, my reading of the evidence is that vaccine passports would provide little benefit at outdoor sports events (which I assume covers most such events). And given objections that have been raised on grounds of privacy and non-discrimination, mandating them for all sports events seems like a very unwise idea.

To begin with, the percentage of people with COVID-19 antibodies is now well above 50% in England and Wales, as this chart from the ONS indicates:

The percentage will be even higher by May 17th, when spectators can finally return to stadiums. And it will be higher still when the next football season begins in August. Due to the seasonality of COVID-19, transmission is likely to be low over the summer, so by the time restrictions might be needed in September, a very large percentage of people will have some form of immunity.

What’s more, evidence suggests that the vast majority of infections occur indoors. This is because wind quickly disperses the virus in outdoor environments, and viral particles degrade more quickly when exposed to sunlight.

In Ireland, only 0.1% of infections could be traced to outdoor activities (though this doesn’t include all the associated indoor activities, such as travel to and from events). And despite England’s packed beaches last summer, the epidemiologist (and SAGE member) Mark Woolhouse told MPs there were “no outbreaks” linked to beaches.

A systematic review of five studies published in The Journal of Infectious Diseases found that less than 10% of infections occurred outdoors. And a recent study published in Environmental Research concluded that “the probability of airborne transmission due to respiratory aerosol is very low in outdoor conditions”.

Chris Whitty has said, “The evidence is very clear that outdoor spaces are safer than indoors.” And a paper by the PHE Transmission group notes, “Evidence continues to suggest that the vast majority of transmission happens in indoor spaces.”

Before the UK’s hugely successful vaccine rollout, the risk of outdoor transmission was low. By the time sports venues re-open on May 17th, the risk will be even lower. While there are some circumstances where Covid certification makes sense (like visiting relatives in care homes), attending outdoor sports events is not one of them. Instead of spending more time checking fans at the entrance, venues would be better off improving ventilation in high-risk spaces.

It’s time to get fans back into stadiums – but they should only have to show a ticket on their way in.

US Calls For Pause on Johnson & Johnson Vaccine Due to Clotting Fears

Federal health agencies in America have called for the rollout of the Johnson & Johnson (J&J) vaccine to be paused immediately due to some recipients developing rare blood clotting disorders within two weeks of being vaccinated. So far, nearly seven million people in the US have received shots of the J&J vaccine, which is not currently used in the UK. Six US recipients of the vaccine have developed disorders involving blood clots, all of them women aged 18-48. The New York Times has the story.

Federal health agencies on Tuesday called for an immediate pause in use of J&J’s single-dose coronavirus vaccine after six recipients in the US developed a rare disorder involving blood clots within about two weeks of vaccination.

All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalised in critical condition. …

“We are recommending a pause in the use of this vaccine out of an abundance of caution,” Dr Peter Marks, Director of the Food and Drug Administration’s Center for Biologics Evaluation and Research, and Dr Anne Schuchat, Principal Deputy Director of the CDC, said in a joint statement. “Right now, these adverse events appear to be extremely rare.”

While the move was framed as a recommendation to health practitioners in the states, the Federal Government is expected to pause administration of the vaccine at all federally-run vaccination sites. Federal officials expect that state health officials will take that as a strong signal to do the same.

Scientists with the FDA and CDC will jointly examine possible links between the vaccine and the disorder and determine whether the FDA should continue to authorise use of the vaccine for all adults or limit the authorisation. An emergency meeting of the CDC’s outside advisory committee has been scheduled for Wednesday.

While the majority of the US’s vaccine supply comes from other sources, it is expected that this pause could “substantially complicate” the nation’s vaccination efforts. The move comes after Europe’s medicines regulator announced last week that it was reviewing possible links between the vaccine and rare blood clots. The jab is expected to be approved for use in the UK “within days“, with 30 million doses having already been ordered by the Government.

J&J said the following in a news release:

We are aware that thromboembolic events including those with thrombocytopenia have been reported with Covid vaccines. At present, no clear causal relationship has been established between these rare events and the J&J Covid vaccine.

The New York Times’s article is worth reading in full.

Stop Press: The European rollout of the vaccine has now been paused, according to a statement released by Johnson & Johnson. The company said: “We have been reviewing these cases with European health authorities. We have made the decision to proactively delay the rollout of our vaccine in Europe.”

Boris Johnson Says Lockdown Not Vaccines Responsible for Drop in Covid Cases and Deaths

Has Boris lost his faith in the vaccines? That’s certainly the impression you’d get from what he has said this morning. Speaking in 10 Downing Street, the Prime Minister said:

The numbers are down of infections and hospitalisations and deaths. But it is very, very important for everybody to understand that the reduction in these numbers in hospitalisations and in deaths and infections has not been achieved by the vaccination programme. People don’t, I think, appreciate that it’s the lockdown that has been overwhelmingly important in delivering this improvement in the pandemic and in the figures that we’re seeing. And so, yes of course the vaccination programme has helped, but the bulk of the work in reducing the disease has been done by the lockdown. So, as we unlock, the result will inevitably be that we will see more infection, sadly we will see more hospitalisation and deaths, and people have just got to understand that.

Notice that he didn’t say it’s a matter of waiting for the vaccines to take effect. It now appears that, regardless of vaccinations operating at full power, the Prime Minister thinks “inevitably” we will see more infection, hospitalisation and death.

The PM added that “at the moment” he couldn’t see “any reason” to change his roadmap for easing lockdown restrictions.

At Lockdown Sceptics, of course, we can give him several reasons for getting a move on. Florida, Texas, Georgia, South Dakota, South Carolina and Mississippi for starters. These states all currently have no restrictions at all, whether because they never had them (South Dakota), because they removed them after the first wave in the spring (Georgia and South Carolina) or in the autumn (Florida), or because they lifted them in the last few weeks (Mississippi and Texas). If lockdown is what brings infections down, what has brought them down in these states?

The claim that lockdowns “control” the coronavirus has no basis in the data or in the evidence-based (as opposed to model-based) scientific literature. No evidence-based study has found a statistically significant relationship between the severity or timing of interventions and Covid cases or death counts. It is “fake news”, to use the current parlance, and scientists and politicians need to stop repeating it as though doing so can make it true.

Looking just at the UK, it’s clear from the data that new daily infections peaked and began to fall before the lockdowns on all three occasions. Chris Whitty even admitted as much to MPs in July in relation to the first lockdown.

According to ONS data, new infections in the winter surge in England peaked in the week ending December 26th, nearly two weeks before the January lockdown and right in the middle of Christmas mingling that was predicted to cause a spike.

This image has an empty alt attribute; its file name is England-ONS-new-infections.png

If lockdowns control the coronavirus then how can this be explained?

On one level it should be welcome that Boris is candidly admitting that the vaccines will not prevent all infections, hospitalisations and deaths. But then no one ever thought they would. The aim was just to make endemic Covid no worse than the usual pathogens we face, which many people believed requires effective vaccines. Now we have vaccines, there is no excuse not to lift restrictions, particularly seeing that places which have remained fully open even without vaccines have not seen catastrophic consequences, and often fared better than places with strict lockdowns.

COVID-19 outbreaks have consistently shown themselves to be self-limiting, regardless of what measures are or are not imposed. In some places the outbreaks are more severe, in some places less so. As with other similar seasonal respiratory pathogens this will be due to a combination of seasonality, the development of population immunity (including from vaccines, where available), the effectiveness of treatments, population density, and numerous other factors that might affect a population’s susceptibility to a particular pathogen. But on no occasion have the models attributing the differences to lockdowns been validated by empirical data.

As the Government appears to be preparing to pivot away from its vaccines-will-save-us narrative, the big danger is that what we get instead is not a freedom that accepts governments cannot prevent all evils, but a future of indefinite restrictions, periodically tightened and loosened, as the myth persists that only such measures are holding back the flood. If we are no longer to see the vaccines as our saviour, it is imperative that the Government shift to a zero restrictions approach, not a zero Covid one, and set us free without further delay.

Cold Weather Takes Shine Off Reopening

According to a retail analyst Springboard, shopping activity didn’t return to pre-pandemic levels yesterday thanks to the cold weather. Meanwhile, only two in five pubs opened in England due to the lack of suitable outside space. The Times has more.

Britain’s notoriously fickle spring weather dampened the high street’s recovery yesterday as lockdown restrictions were eased.

People going to shops, pubs and restaurants for the first time in more than three months endured cold conditions and even snow. On the south coast, temperatures were as low as 5C, half the usual average for the time of year. Little Rissington in Gloucestershire recorded 4cm of snow.

Shoppers who braved the cold appeared to be preparing to party. John Lewis reported that decanters, tumblers and highball glasses were “by far” the most popular purchases yesterday morning, with champagne and gift bags the two next most popular categories.

Some stores, such as Primark and Ikea, had queues first thing, but the number of people visiting high streets overall was a quarter lower than the equivalent day two years ago.

The retail analyst Springboard said that shopping centres had fared better, although they were still down on a normal day, suggesting that the weather had been a deterrent for many people.

Clive Black, a retail analyst at Shore Capital, said: “The cold and snow will have kept an awful lot of people at home, particularly older people. That said, the pandemic is still casting a long shadow over retail.

“Shoppers are more cautious and the shift online represents a big structural challenge to high street stores.”

The British Beer and Pub Association estimated that only two in five pubs reopened yesterday because most venues lack a big enough outdoor space to trade profitably. It acknowledged that the cold weather would have deterred some customers.

You can read the article here.

Kent Covid Variant No More Severe, Studies Show

Two new studies have shown that the “Kent” Covid variant – which Boris Johnson previously said “may be associated with a higher degree of mortality” – does not cause more severe disease, despite being more transmissible. The Financial Times has the story.

The highly contagious B.1.1.7 coronavirus variant, which originated in Kent and now dominates Covid transmissions across Europe and North America, does not cause more severe disease, according to two new studies. 

The research, published on Monday night, appeared to contradict earlier conclusions that B.1.1.7 infection led to more serious symptoms and was about 60% more lethal than previous variants of the virus.

The new studies used different methods. One team compared illness severity in patients infected with B.1.1.7 and other variants at two London hospitals – University College London Hospital and North Middlesex Hospital. The other combined data collected by the UK’s Zoe Covid Symptom Study mobile app with surveillance records from the Covid Genomics UK Consortium and Public Health England.

Both studies confirmed previous findings that B.1.1.7 is at least 35% more transmissible. But, once the data were fully corrected for demographic and epidemiological factors, neither study found an association between the variant and more severe disease symptoms.

Dr Eleni Nastouli, the lead author of the UCL study which has been published in the Lancet Infectious Diseases journal, said the study helped researchers properly analyse the severity of the variant.

One of the real strengths of our study is that it ran at the same time that B.1.1.7 was emerging and spreading throughout London and the south of England.

Analysing the variant before the peak of hospital admissions and any associated strains on the health service gave us a crucial window of time to gain vital insights into how B.1.1.7 differs in severity or death in hospitalised patients from the strain of the first wave.

After Boris Johnson said in a January news briefing that “the new variant… may be associated with a higher degree of mortality”, MPs accused the Government of “scaremongering” about the virus without strong supporting evidence – evidence which even Chief Scientific Officer Sir Patrick Vallance said was “weak”.

The Covid Recovery Group of Tory backbenchers and business chiefs are growing increasingly alarmed at suggestions lockdown could stretch well into summer despite Britain’s vaccination programme  

Tory backbencher Craig Mackinlay told MailOnline some of the scientific warnings were reminiscent of Project Fear and every time there was hope of easing lockdown there was “a new twist”.

The FT‘s report is worth reading in full.

England’s Rollout of the Moderna Vaccine Begins

England is to begin giving out doses of the Moderna jab – the third vaccine introduced in its national rollout – as everyone over the age of 50 is offered their first dose of a vaccine. Bookings are also opening online for those aged 45-49 to get vaccinated. Wales was the first British country to begin rolling out the Moderna jab last week and has since reached the milestone of vaccinating half of its population. Seventeen million doses of the vaccine have been bought by the Government, which is enough to vaccinate about 8.5 million people. BBC News has the story.

England is giving out its first doses of the Moderna jab, the third Covid vaccine in the nation’s rollout.

It will be available at 21 sites, including the Madejski Stadium in Reading and the Sheffield Arena. …

More than 32 million people in the UK have now had a first dose of a coronavirus vaccine and nearly 7.7 million have had both doses.

Prof Stephen Powis, Medical Director of NHS England, said having “a third jab in our armoury” marked another “milestone” in the vaccine programme.

He said more sites would offer the Moderna vaccine as further supplies arrive. …

The Moderna vaccine uses a similar innovative RNA technology to the Pfizer jab, but it is stored at lower temperatures of -20C like a normal freezer, compared to -70C for the Pfizer vaccine. It can also be stored for 30 days at normal fridge temperatures. …

Trial results suggested efficacy against the disease was 94.1%, and vaccine efficacy against severe Covid-19 was 100%.

More than 30,000 people in the US took part in the trial, from a wide range of age groups and ethnic backgrounds.

The vaccine will be used alongside Pfizer’s Covid jab as an alternative to that produced by AstraZeneca for people below the age of 30 (possibly even those aged 30-39) because of the AZ jab’s link to blood clots.

The NHS said the Moderna and Pfizer jabs would be used for under-30s who were due to receive the AstraZeneca vaccine but whose appointments were rearranged.

Last week, the Joint Committee on Vaccination and Immunisation – which advises the UK Government on vaccines – recommended that under-30s be offered an alternative to the AstraZeneca vaccine, out of the “utmost caution” following reports of blood clots in about four in one million cases.

The NHS said the majority of appointments in April were for second doses, but first dose appointments were still available for people in the initial priority groups who have not yet been immunised – including the over-50s, people who are clinically vulnerable or those working in health or social care.

The vaccine will, however, only be offered as an alternative where possible.

The BBC News report is worth reading in full.

The Government Has Bought into a Dangerous Myth of “100% Protection”

UK scientists are continuing to highlight Chile as a warning of what can happen even with widespread vaccination. The new angle is to draw attention to the poor efficacy of the Chinese vaccines. The Mail has the story.

Professor Ian Jones, a virologist at the University of Reading, told MailOnline the figures from Chile suggest the Chinese vaccines “will not be enough to stop the virus circulating”.

Despite fully vaccinating a quarter of its population and getting a single dose to 40%, Chile has seen its infection rate double since mid-February, rising from 177 daily cases per million to 372. More than 80% of the country has been forced to retreat back into lockdown, which was used by No 10’s scientists as proof the UK is not out of the woods. 

However, the South American nation is primarily using the CoronaVac vaccine, made by Chinese pharma giant Sinovac, which a University of Chile study found was only 3% effective after the first dose, rising to 56.5% two weeks after the second. Another study in Brazil found efficacy could be as low as 50%, which just meets the World Health Organization’s threshold for an acceptable vaccine.  

For comparison, the Pfizer and Moderna vaccines have efficacy rates of 95% and 94%, respectively, while AstraZeneca’s is about 79%. Trials of tens of thousands of patients given the US and British jabs found they stopped up to 100% of hospitalisations and deaths, compared to CoronaVac’s 84%. 

Even China appeared to acknowledge the shortcomings of its vaccines at the weekend, when Gao Fu, the director of the Chinese Center for Disease Control and Prevention, admitted “protection rates of existing vaccines are not high. It’s now under formal consideration whether we should use different vaccines from different technical lines for the immunisation process.”

However, since then the Chinese Government has put out an interview with Fu where he claims his comments were “a complete misunderstanding”. He said: “The protection rates of all vaccines in the world are sometimes high, and sometimes low. How to improve their efficacy is a question that needs to be considered by scientists around the world.”

Chilean Science Minister Andres Couve also came to the defence of the Sinovac vaccine. On Sunday he revealed that the health ministry will shortly publish a real world study on the efficacy of the CoronaVac vaccine, saying it was important to focus on the data and the effectiveness in reducing serious illness. Likewise, Heriberto Garcia, head of Chile’s Public Health Institute, said people should ignore headlines. “The University of Chile study and the study the Health Ministry will release say the same thing: the number of people who fall ill and are hospitalised has decreased,” he told local newspaper La Tercera. “We are going down the right path.”

A number of UK scientists criticised the Chinese vaccines, according to the Mail.

Professor Gabriel Scally, a public health expert at the University of Bristol, told MailOnline the crisis in Chile “was not a great tribute to the Chinese vaccines”.

He added: “They haven’t been approved by any of the major medical regulators and there is very limited research evidence, they certainly don’t appear to have a high level of effectiveness in the real world. And in the absence of data it’s very difficult to know [how effective they really are]. The only benefit of them is the fact they’re cheap.”

On whether countries rolling out Chinese vaccines should fear a resurgence of the virus, he said: “I think they would have a right to be worried.”

But he admitted that a vaccine that’s partially effective is better than none at all. 

He told MailOnline: “That 50% mark is the line in the sand that’s drawn by the WHO, which is great. But I think it’s beginning to dawn on people these [Chinese] vaccines aren’t going to solve the problem completely.”

Professor Scally said the UK was “in a different place” because it has highly effective vaccines in its arsenal, adding: “As long as we take it easy [coming out of lockdown] we should be fine.”

However, other scientists see Chile as a warning about the limited effectiveness of vaccines more generally. Chris Whitty told a Downing Street press conference last week: “We want to do things in a steady way because the assumption that just because you vaccinate lots of people, then the problem goes away, I think Chile is quite a good corrective to that.”

Sir David King, a former UK Chief Scientific Adviser, told Sky News yesterday:

From the point of view of the population itself, we’re all dying to get out of lockdown. From the point of view of the epidemic, I think it’s all a little bit more worrying. Chile is a country where the rate of vaccination amongst the population was third highest in the world – they were ahead of us in terms of the number of people who have had the vaccine – and they’re suddenly now into a third wave. They now have 7,600 cases a day and the total number of people in Chile now who have Covid is over a million. So what has happened in Chile is very, very surprising – a high percentage of people have been vaccinated, but here’s a variant of the disease coming through the country.

As Lockdown Sceptics noted last week, Chile is not a good a comparison for the UK, firstly because it appears to be using a less effective vaccine, and partly because it is in the southern hemisphere and so is currently in the middle of autumn. It is the equivalent of mid-October there, so some increase in respiratory disease should be expected as the winter flu season gets underway. The country is also some way behind the UK in terms of Covid deaths per million, which puts the comparison into some perspective.